Key Takeaways:
At the American Academy of Dermatology (AAD) Annual Meeting 2026, the show floor reflected a broader shift underway in the dermatology and skincare industries: one where clinical credibility and consumer engagement are no longer mutually exclusive. Once defined by rows of white-coated experts and data-heavy presentations, the AAD meeting has increasingly become a space where heritage pharmaceutical brands, prestige beauty players, and digitally native disruptors converge, not just to present science but to stage experiences.
From traditional, research-led booths anchored in clinical trials and symposiums to immersive, consumer-facing activations designed for social sharing and real-world interaction, brands approached AAD 2026 with markedly different playbooks. Some leaned into their medical roots, spotlighting decades of dermatological research and physician-led education. Others blurred the lines between clinic and culture, hosting offsite events, influencer-led moments, and tactile brand experiences that extended far beyond the convention center walls.
The result was a dynamic spectrum of presence: from Arey’s salon takeover and Obagi’s hands-on injectable demonstrations to EltaMD’s high-energy community events and Bubble’s playful yet science-backed storytelling. Together, these activations underscored a new reality for AAD: one in which engaging dermatologists increasingly means speaking both the language of science and the cadence of modern consumer culture. BeautyMatter outlines the standout booths from AAD 2026.
Lancôme: At the AAD, Lancôme unveiled its Longevity MD Advisors Board, bringing together board-certified doctors from diverse medical specialties, each with a distinct field of expertise and vision. Members include Dr. David Luu, Dr. Tiffany Moon, Dr. Gabrielle Lyon, and Dr. Amy Killen, spanning longevity medicine, nutrition science, regenerative medicine, and public education. The launch of the board coincided with a booth highlighting the brand's new Absolue Longevity MD range, its first longevity-focused skincare line built on Longevity Integrative Science and formulated with Mitopure (Urolithin A) from the Swiss biotech company Timeline.
Arey: The brand hosted a “wash & style” event at the nearby salon, Onyx & Co, to treat dermatologists to a blowout before heading to the show floor. From 7 a.m. to 2 p.m. on Friday, a total of 20 derms and three media in town for AAD stopped by to meet with co-founder Jay Small; learn about the brand; its new launch Good Night, Grey; and hear more about the science-backed, clinical formulas. The brand also presented an e-poster at AAD with its clinical study results on display.
Obagi: The brand hosted three editors from beauty publications and four influencers in the aesthetics and medical space for a weekend of celebrating the brand’s two new launches, Obagi’s NU-GEN Serum and its first expansion into medical aesthetics, MagIQ hydalruonic acid filler. Dr. Suzan Obagi spoke to booth visitors, talking them through the filler firsthand using sample syringes. Obagi also hosted two dinners celebrating the launches.
Parëva Beauty: Smitha Rao, scientist and CEO of Parëva Beauty, hosted a booth at the AAD to highlight the brand's Coll20 Gel Cream Moisturizer. The brand showed at the AAD to further its mission to invest in the dermatology channel and aestheticians, alongside its current distribution points, Credo in the US and Cult Beauty in the UK, as well as DTC.
EltaMD: Kicking off AAD weekend, the brand hosted an Après Sun event at The Thompson Hotel, bringing together 200+ dermatologists and industry insiders to highlight its core pillars of protection, performance, and community. The evening contained a live band and interactive moments, including a dimensional photo booth, the “Clear Confessionals” content studio, and an embroidery station with custom bags and scarves. The guest list included leading dermatologists Dr. Sandra Lee, Dr. Neera Nathan, Dr. Chris Tomassian, Dr. Lindsey Zubritsky, Dr. Mamina Turegano, and Dr. Dustin Portela.
At the conference, EltaMD’s booth was designed to translate clinical efficacy into an engaging visual experience. The booth featured a UV Clear Collection Station, inviting guests to try the latest product powered by Zinc-AOX Pro and 5% niacinamide, the UV Skin Recovery Station spotlighting UV Skin Recovery SPF50, UV Daily Collection Station highlighting the UV Daily lineup including UV Daily SPF 40 and UV Daily Hydration+ SPF 50, and experiential and content-driven moments such as a photobooth. For every guest who shared their photobooth image and tagged @eltamdskincare and @curemelanoma, EltaMD donated a bottle of UV Daily to the Melanoma Research Foundation.
Bubble: Returning for its second year at the AAD, Bubble focused on earning trust among dermatologists. The brand highlighted its four key pillars: Cleanse, Treat, Moisturize, and Protect. For each pillar, Bubble stood behind a claim: immediate sebum reduction (cleanse), visible acne improvement in one week (treat), barrier-repairing hydration (moisturize), and mineral SPF that performs across every skin tone (protect). While focusing on the importance of science, Bubble aimed to keep its booth fun, proving that dermatological brands can be “credible without being distant.”
Byoma: At the conference, the brand worked to reinforce its position as a science-led, barrier-first skincare business by presenting its latest clinical research and long-term vision for skin health. Central to its presence was the unveiling of a newly published abstract described as “a breakthrough in skin barrier research” alongside a commitment to testing, exemplified by over 220 clinical trials and 130,000 skin measurements conducted over four years. Byoma used the platform to engage directly with dermatologists and industry experts, emphasizing that barrier care is not a trend but the foundation of sustainable skin health. Its booth balanced clinical credibility with modern, design-led storytelling, spotlighting its five-step system, proprietary technology, and future innovations while challenging traditional, sterile aesthetics in dermatology spaces.
ISDIN: The skincare brand showcased its top SKUs to booth attendees through Science Talks and the ISDIN Symposium, presented by Dr. Josep Malvehy, Dr. Jean Krutmann, Dr. Anthony Brown, and Dr. Jaime Piquero. A key focus was the brand's Melatonik, a 3-in-1, oil-based night serum. At the booth, experts and derms shared educational content, answering questions about SPF and debunking common myths, such as the belief that sunscreen isn't needed when wearing makeup.
Kenvue: Neutrogena and Aveeno, part of the Kenvue portfolio, showcased new science and addressed top consumer concerns at the 2026 AAD at its 12,000-square-foot booth. Neutrogena shared its new Collagen Bank Vitamin C Serum. For acne solutions, Neutrogena displayed its Clear Pore Cleanser/Mask, along with a study showing the product delivers an effective level of benzoyl peroxide (3.5%) for daily acne management. Aveeno focused on hydration, unveiling its Skin Relief Healing Ointment, formulated with triple oat and glycerin. Kenvue also revealed a study containing data on Bemotrizinol, a broad-spectrum UV filter now under consideration for approval in the US.
Dr. Dennis Gross Skincare: Dr. Dennis Gross Skincare’s booth at AAD functioned as an immersive brand experience centered on clinical credibility and innovation. At its first appearance at the conference, the booth emphasized the brand’s dermatologist-led foundation and scientific approach to skincare. The exhibit brought together product displays, team interactions, and opportunities for attendees to engage directly with the brand’s formulations and expertise, focusing heavily on its most popular SKUs, including the Alpha Beta Daily Universal Skin Pads.
Epionce: Dr. Carl Thornfeldt’s brand, founded on over 40 years of dermatology experience and 20 years of clinical research, focused on its mask offerings at the AAD. Two products were particularly highlighted: the Intense Recharge Mask and the Enriched Firming Mask. Visitors to the booth were able to chat with Dr. Thornfeldt and test the masks, with some receiving SKUs for at-home trials.
Dr. Wolff Group: The German pharmaceutical brand showcased what it called “the next evolution of haircare” with new SKUs from Alpecin. The products combine caffeine, said to stimulate hair root activity, with dimethylglyoxime (DMG), said to support microcirculation responsible for nutrient supply. The booth focused on hair loss as a late-onset side effect of GLP1 treatments, guiding patients towards a drug-free haircare regimen to prevent further hair loss.
Vaseline: The cult-trusted brand showed up at the AAD with a focus on “tub to tube,” sharing the latest innovation of its original healing jelly in a new tube format that makes it more convenient and portable. The booth also highlighted beauty products such as gel oils and the Cocoa Shimmer Jelly Stick, as well as core lotions. Visitors could engage with a photobooth, sampling at scale, and a social-based giveaway.
Glow Recipe: The K-beauty brand debuted at the AAD in 2026, focusing on its clinical testing data and VISIA results, as well as the formulation behind its viral Toner Pads. The booth invited guests to immerse themselves in the product, receive treatments, and learn about Korean innovations. The booth emphasized sustainability, as it was a repurpose of the brand's Sephoria showing, which was at the retailer’s event a week prior to the AAD.
Shiseido: The brand made its presence at AAD 2026 felt through a science-first approach, prioritizing clinical exchange over traditional brand promotion. Drawing on more than 110 years of R&D, the brand centered its activation around structured researcher-led walkthroughs on sun protection and peer-to-peer dialogue with dermatologists, while also encouraging hands-on product testing to demonstrate real-world usability. At the core of its showcase was Mineral i-shield, a novel UV protection film technology designed to improve dispersion, minimize white cast, and enhance wearability—signaling a broader shift toward preventive care and patient adherence in dermatology.
AAD 2026 made clear that the future of dermatology lies in the intersection of clinical rigor and cultural relevance. As brands compete for attention, those that translate science into tangible, engaging experiences are best positioned to earn both dermatologist trust and consumer loyalty. In this evolving landscape, credibility is no longer just proven; it’s performed.
